SIGNALING OF PREGNANE X RECEPTOR
妊娠 X 受体的信号传导
基本信息
- 批准号:6387275
- 负责人:
- 金额:$ 23.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-07-01 至 2004-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Adapted from the applicant's abstract): Cytochrome P4503A (CYP3A)
enzymes involve the metabolism of two thirds of drugs and other xenobiotics.
Induction of CYP3A enzymes by many compounds is known as an important
contributing factor to many failures of therapy or severe toxicity. CYP3A
induction is featured by marked species difference, structural diversity of the
inducers, and inter-individual variation. Analyses of CYP3A promoters locate
three cis-response elements likely involved in CYP3A induction. A reporter gene
construct containing one of the elements can be transactivated by an orphan
receptor designated the pregnane X receptor (PXR), and the differential
activation of mouse and human PXRs by several compounds largely reflects the
species difference observed in vivo. The central hypothesis of the proposed
studies is that PXR plays a determinant role in CYP3A induction and
multiplicity/polymorphism, along with inducibility of PXR, are responsible for
the species difference, inducer diversity and individual variation. The
specific aims of this project are: (1) to determine the
multiplicity/polymorphism of PXR in humans; (2) to determine the essentiality
of PXR in the CYP3A induction; (3) to determine the synergistic effects of PXR
inducers on PXR activator-mediated CYP3A induction; and (4) to determine
important residues of PXRs in conferring CYP3A induction by rifampicin (RIF)
and pregnenolone 16alpha-carbonitrile (PCN). As part of the studies to
determine the molecular basis for the existence of multiple forms and
polymorphic variants of PXRs in humans, a cDNA-trapping method will be used to
screen cDNA libraries from hepatic and extrahepatic tissues. Transient
cotransfection experiments with a CYP3A reporter will be conducted to determine
the activation profile of each PXR. To determine the essentiality of PXR in
CYP3A induction, PXR antisense constructs will be tested for their ability to
block CYP3A induction; and PXR chimeras with a ligand binding domain from
another species will be tested for their ability to modulate CYP3A expression
in response to species-selective activators. To determine the synergistic
effects of PXR inducers on PXR activator-mediated CYP3A induction, rats and
hepatocytes will be treated with PXR inducers, PXR activators, or in
combination; induction of CYP3A will be determined by Northern and Western blot
analyses. Site-directed mutagenesis experiments will be conducted to determine
functionally important residues of PXRs in conferring CYP3A induction by RIF
and PCN. Significant progress has been made toward the proposed objective.
Full-length cDNAs encoding multiple forms of rodent and human PXRs have been
isolated. Several compounds are found to drastically increase rPXR-1 mRNA
levels. These results support our hypothesis that multiplicity and polymorphism
along with inducibility of PXR are responsible for species difference, inducer
diversity and individual variation featured by CYP3A induction.
描述(改编自申请人的摘要):细胞色素P4503A(CYP3A)
酶涉及三分之二的药物和其他异种生物的代谢。
许多化合物诱导CYP3A酶被称为重要
导致许多治疗或严重毒性失败的因素。 CYP3A
诱导由明显的物种差异,结构多样性的特征
诱导者和个体间差异。 CYP3A启动子的分析定位
CIP3A诱导可能涉及的三个顺式反应元件。记者基因
包含其中一个元素之一的构造可以通过孤儿进行反式激活
受体指定妊娠X受体(PXR),差异
几种化合物对小鼠和人PXR的激活主要反映了
体内观察到的物种差异。提议的中心假设
研究是,PXR在CYP3A诱导和
多样性/多态性以及PXR的诱导性,负责
物种差异,诱导剂多样性和个体变异。这
该项目的具体目的是:(1)确定
PXR在人类中的多样性/多态性; (2)确定重要性
CYP3A诱导中的PXR; (3)确定PXR的协同作用
PXR激活剂介导的CYP3A诱导诱导; (4)确定
PXR的重要残基在利福平(RIF)授予CYP3A诱导中
和妊娠16Alpha-碳硝基(PCN)。作为研究的一部分
确定存在多种形式的分子基础和
PXR的多态性变体在人类中,将使用一种cDNA捕获方法来
从肝和肝外组织中筛选cDNA文库。瞬态
将对CYP3A报告基因进行共转染实验,以确定
每个PXR的激活曲线。确定pxr的本质
CYP3A诱导,PXR反义构建体的能力将测试
块CYP3A诱导;和PXR嵌合体,具有配体结合域的
将测试另一个物种的调节CYP3A表达的能力
响应物种选择性激活剂。确定协同作用
PXR诱导剂对PXR激活剂介导的CYP3A诱导,大鼠和大鼠的影响
肝细胞将用PXR诱导剂,PXR激活剂或IN治疗
组合; CYP3A的诱导将由Northern和Western印迹确定
分析。将进行定向诱变实验以确定
PXR在功能上重要的残基在RIF授予CYP3A诱导中
和PCN。对拟议的目标取得了重大进展。
编码多种形式的啮齿动物和人PXR的全长cDNA已
孤立。发现几种化合物大大增加了RPXR-1 mRNA
水平。这些结果支持我们的假设,即多样性和多态性
除PXR的诱导性外,还导致物种差异,诱导剂
CYP3A诱导的多样性和个体变异。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bingfang Yan其他文献
Bingfang Yan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bingfang Yan', 18)}}的其他基金
Functional connection between the growth factor independence-1b and post-neonatal regulation of biotransformation genes
生长因子独立1b与生物转化基因新生儿后调控之间的功能联系
- 批准号:
10681617 - 财政年份:2023
- 资助金额:
$ 23.04万 - 项目类别:
Metabolism-based interactions and organ-targeted delivery of molnupiravir, nirmatrelvir and remdesivir
莫努匹拉韦、尼马曲韦和瑞德西韦基于代谢的相互作用和器官靶向递送
- 批准号:
10561381 - 财政年份:2023
- 资助金额:
$ 23.04万 - 项目类别:
Circular RNA regulators of common drug-eliminating genes
常见药物消除基因的环状RNA调节因子
- 批准号:
10507852 - 财政年份:2022
- 资助金额:
$ 23.04万 - 项目类别:
Circular RNA regulators of common drug-eliminating genes
常见药物消除基因的环状RNA调节因子
- 批准号:
10684130 - 财政年份:2022
- 资助金额:
$ 23.04万 - 项目类别:
Metabolic basis for lipid abnormality with anti-HIV tenofovir prodrugs
抗HIV替诺福韦前药脂质异常的代谢基础
- 批准号:
10026409 - 财政年份:2020
- 资助金额:
$ 23.04万 - 项目类别:
Metabolic basis for lipid abnormality with anti-HIV tenofovir prodrugs
抗HIV替诺福韦前药脂质异常的代谢基础
- 批准号:
10254403 - 财政年份:2020
- 资助金额:
$ 23.04万 - 项目类别:
Biodegradable hollow CUS nanoparticles for photothermal cancer therapy
用于光热癌症治疗的可生物降解的中空 CUS 纳米颗粒
- 批准号:
9657958 - 财政年份:2018
- 资助金额:
$ 23.04万 - 项目类别:
Interplay between metabolism and FXR activation in scoparone signaling
scoparone 信号传导中代谢与 FXR 激活之间的相互作用
- 批准号:
8574018 - 财政年份:2013
- 资助金额:
$ 23.04万 - 项目类别:
BRIN: URI: TMSR/FUNCTIONAL GENOMICS & PROTEOMICS SUBCORE
BRIN: URI: TMSR/功能基因组学
- 批准号:
6973512 - 财政年份:2004
- 资助金额:
$ 23.04万 - 项目类别:
相似国自然基金
硫化氢抑制采后枸杞乙烯生物合成及其信号转导的机理研究
- 批准号:32360612
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
生物钟核心转录因子PRRs调控JA信号转导及植物对灰霉菌防御的分子机理
- 批准号:32370606
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于“丛枝菌根真菌-激素信号转导-转录因子-L/ODC基因”调控路径解析苦参生物碱生物合成的调控机制
- 批准号:82304678
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
组蛋白乙酰化修饰ATG13激活自噬在牵张应力介导骨缝Gli1+干细胞成骨中的机制研究
- 批准号:82370988
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
新型信号转导光电化学免疫生物传感对肝癌相关分子标志物检测新方法研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
HORMONE ACTION IN THE OVARY: ROLE OF CALCIUM IONS
卵巢中的激素作用:钙离子的作用
- 批准号:
2888870 - 财政年份:1984
- 资助金额:
$ 23.04万 - 项目类别: